Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Aggravation of herpetic stromal keratitis after murine epidermal grown factor topical application.

Romano A, Peisich A, Wasserman D, Gamus D.

Cornea. 1994 Mar;13(2):167-72.

PMID:
8156789
2.

Efficacy of cobalt chelates in the rabbit eye model for epithelial herpetic keratitis.

Asbell PA, Epstein SP, Wallace JA, Epstein D, Stewart CC, Burger RM.

Cornea. 1998 Sep;17(5):550-7.

PMID:
9756451
3.

Topical antisense-oligonucleotides targeting IFN-gamma mRNA improve incidence and severity of herpetic stromal keratitis by cytokine specific and sequence unspecific effects.

Wasmuth S, Bauer D, Steuhl KP, Heiligenhaus A.

Graefes Arch Clin Exp Ophthalmol. 2008 Mar;246(3):443-51. Epub 2007 Nov 21.

PMID:
18030487
4.

Large Amounts of Reactivated Virus in Tears Precedes Recurrent Herpes Stromal Keratitis in Stressed Rabbits Latently Infected with Herpes Simplex Virus.

Perng GC, Osorio N, Jiang X, Geertsema R, Hsiang C, Brown D, BenMohamed L, Wechsler SL.

Curr Eye Res. 2016;41(3):284-91. doi: 10.3109/02713683.2015.1020172. Epub 2015 Apr 10.

5.

Cidofovir and experimental herpetic stromal disease.

Kaufman HE, Varnell ED, Thompson HW.

Arch Ophthalmol. 1999 Jul;117(7):925-8.

PMID:
10408458
6.

Moderation of herpetic stromal keratitis by basic fibroblast growth factor.

Gamus D, Romano A, Rubinstein M, Savion N.

Exp Eye Res. 1996 Jul;63(1):1-8.

PMID:
8983954
7.

Latanoprost increases the severity and recurrence of herpetic keratitis in the rabbit.

Kaufman HE, Varnell ED, Thompson HW.

Am J Ophthalmol. 1999 May;127(5):531-6.

PMID:
10334345
8.

Application of FGF-2 to modulate herpetic stromal keratitis.

Kim B, Lee S, Kaistha SD, Rouse BT.

Curr Eye Res. 2006 Dec;31(12):1021-8.

PMID:
17169840
10.

Stromal keratitis induced by a unique clinical isolate of herpes simplex virus type 1.

Sakai Y, Minagawa H, Ishibashi T, Inomata H, Mori R.

Ophthalmologica. 1994;208(3):157-60.

PMID:
8065701
11.

Herpes simplex virus latency in human cornea.

Shimomura Y, Mori Y, Inoue Y, Kiritooshi A, Ohashi Y, Manabe R.

Jpn J Ophthalmol. 1993;37(3):318-24.

PMID:
8295371
12.

Effect of topical cyclosporin A on herpetic stromal keratitis in a mouse model.

Yoon KC, Heo H, Kang IS, Lee MC, Kim KK, Park SH, Cho KO.

Cornea. 2008 May;27(4):454-60. doi: 10.1097/ICO.0b013e318160602d.

PMID:
18434850
13.

Treatment of HSV-1 stromal keratitis with topical cyclosporin A: a pilot study.

Heiligenhaus A, Steuhl KP.

Graefes Arch Clin Exp Ophthalmol. 1999 May;237(5):435-8.

PMID:
10333113
14.

Topical treatment with nerve growth factor in an animal model of herpetic keratitis.

Lambiase A, Coassin M, Costa N, Lauretti P, Micera A, Ghinelli E, Aloe L, Rama P, Bonini S.

Graefes Arch Clin Exp Ophthalmol. 2008 Jan;246(1):121-7. Epub 2007 May 4.

PMID:
17479276
15.

Topical administration of HSV gD-IL-2 DNA is highly protective against murine herpetic stromal keratitis.

Inoue T, Inoue Y, Hayashi K, Yoshida A, Nishida K, Shimomura Y, Fujisawa Y, Aono A, Tano Y.

Cornea. 2002 Jan;21(1):106-10.

PMID:
11805518
16.

The severity of herpes simplex viral keratitis in mice does not reflect the severity of disease in humans.

Rinne JR, Abghari SZ, Stulting RD.

Invest Ophthalmol Vis Sci. 1992 Feb;33(2):268-72.

PMID:
1310955
17.

[Battle with herpes for 37 years].

Shimomura Y.

Nippon Ganka Gakkai Zasshi. 2015 Mar;119(3):145-66; discussion 167. Review. Japanese.

PMID:
25854108
18.

In vitro and in vivo effects of polyhexamethylene biguanide against herpes simplex virus infection.

Valluri S, Fleming TP, Laycock KA, Tarle IS, Goldberg MA, Garcia-Ferrer FJ, Essary LR, Pepose JS.

Cornea. 1997 Sep;16(5):556-9.

PMID:
9294689
19.

Increased severity of herpes simplex virus type 1-induced keratitis in Hox A5 transgenic mice.

Galle LE, Taus NS, Maggs DJ, Moore CP, Mitchell WJ.

Curr Eye Res. 2001 Dec;23(6):435-42.

PMID:
12045893
20.

In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.

Anand BS, Hill JM, Dey S, Maruyama K, Bhattacharjee PS, Myles ME, Nashed YE, Mitra AK.

Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2529-34.

PMID:
12766053

Supplemental Content

Support Center